These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3913944)

  • 41. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [NSAID-induced ulcers--therapy and prevention].
    Rösch W
    Z Rheumatol; 1995; 54(1):2-8; discussion 9-11. PubMed ID: 7725807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
    Boixeda de Miquel D
    Rev Esp Enferm Dig; 1997 Dec; 89(12):875-7. PubMed ID: 9494374
    [No Abstract]   [Full Text] [Related]  

  • 44. Continuous infusion or repeated intravenous bolus injection of high-dose omeprazole in patients at high risk of rebleeding from peptic ulcers?
    Netzer P; Inauen W
    Am J Gastroenterol; 2006 Dec; 101(12):2888-9; author reply 2889. PubMed ID: 17227532
    [No Abstract]   [Full Text] [Related]  

  • 45. [Modified triple therapy: what degree of acid inhibition is necessary?].
    Müller P; Simon B
    Leber Magen Darm; 1996 May; 26(3):171-3. PubMed ID: 8709832
    [No Abstract]   [Full Text] [Related]  

  • 46. [Capsule endoscopy study of gastrointestinal tolerance. Coxibes superior to NSAID plus antacid].
    MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347082
    [No Abstract]   [Full Text] [Related]  

  • 47. [Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
    Lux G
    Fortschr Med; 1996 Aug; 114(22-23):273-5. PubMed ID: 8974961
    [No Abstract]   [Full Text] [Related]  

  • 48. [What is the current therapeutic role of omeprazole in gastroduodenal ulcer disease?].
    Gisbert JP; Boixeda D; Martín de Argila C
    Rev Esp Enferm Dig; 1997 Feb; 89(2):116-23. PubMed ID: 9115818
    [No Abstract]   [Full Text] [Related]  

  • 49. [New data on clinical response to therapeutic effects of gastrozepin].
    Zaĭtseva EI; Titova OV; Melekhova LS; Makarenko TG; Sosina TE
    Klin Med (Mosk); 1996; 74(3):49-50. PubMed ID: 8926704
    [No Abstract]   [Full Text] [Related]  

  • 50. [Evaluation of the clinical effectiveness of modern antiulcer drugs].
    Komarov FI; Pogromov AP; Egorov AP
    Ter Arkh; 1980; 52(8):8-11. PubMed ID: 7256595
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of gastroduodenal ulcers with the use of endoscopic polymers].
    Panchenkov RT; Semenov VV; Popov IuP; Demidov DA
    Khirurgiia (Mosk); 1981 Mar; (3):95-8. PubMed ID: 7265670
    [No Abstract]   [Full Text] [Related]  

  • 52. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
    Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
    J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Time and conditions of ulcer healing in peptic ulcer].
    Salupere VP; Maaroos KhI; Uĭbo RM; Kallikorm AP
    Ter Arkh; 1981; 53(2):19-20. PubMed ID: 7221926
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pharmacotherapy of peptic ulcer].
    Ryss ES
    Klin Med (Mosk); 1980 Jan; 58(1):16-21. PubMed ID: 6988638
    [No Abstract]   [Full Text] [Related]  

  • 55. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
    Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A
    Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K; Nowak A; Marlicz K; Depczyńska A; Dzieniszewski J; Milewski B; Gabryelewicz A; Kosidło S
    Pol Tyg Lek; 1984 Nov; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract]   [Full Text] [Related]  

  • 57. Use new diagnostic know-how to improve prevention, treatment of peptic ulcer disease.
    Healthc Demand Dis Manag; 1997 Oct; 3(10):154-5. PubMed ID: 10176754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current therapy of Helicobacter pylori-induced chronic gastritis and/or peptic ulcer].
    Hentschel E
    Wien Klin Wochenschr; 1994; 106(17):543-6. PubMed ID: 7975668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Criteria for subsidizing ulcer therapy].
    Halver B
    Ugeskr Laeger; 1989 Sep; 151(38):2442-4. PubMed ID: 2800022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.